BioCentury
ARTICLE | Financial News

Shanghai Henlius to move forward with Hong Kong listing

September 28, 2018 7:26 PM UTC

Shanghai Fosun Pharmaceutical Group Co. Ltd. (Shanghai:600196; HKSE:2196) said on Sept. 27 its board approved a resolution to list Shanghai Henlius Biotech Inc. (Shanghai, China) on the Hong Kong stock exchange.

Shanghai Henlius, a JV between Fosun and Henlius Biopharmaceuticals Co. Ltd. (Shanghai, China), is developing biosimilar and novel mAbs for cancer and autoimmune indications. Fosun has a 61.1% stake in Shanghai Henlius...